Table 4.
Summary of heart rate model fits using a linear model collapsing all three doses. Peak heart rate is described by both the maximum heart rate from ephedrine treatment and the % change from placebo condition
| Subject | Se (%Δ·l µg−1) | Peak heart rate (beats min−1) (%Δ) |
|---|---|---|
| 1 | 0.13 | 72 (38) |
| 2 | 0.17 | 86 (37) |
| 3 | 0.15 | 101 (33) |
| 4 | 0.065 | 76 (23) |
| 5 | 0.056 | 76 (30) |
| 6 | 0.18 | 97 (49) |
| 7 | 0.078 | 112 (39) |
| 8 | 0.31 | 77 (57) |
| Mean | 0.14 | 87 (38) |
| SD | 0.08 | 15 (11) |
| Median | 0.14 | 82 (38) |
| Pooled* | 0.11 | – |
Se, rate of change of the % change in heart rate from placebo condition; peak heart rate; highest % change in heart rate in the effect-time profile;
*
parameters derived by modelling data from all subjects (n = 8).